Triptolide suppresses 5-lipoxygenase metabolic pathway and induces apoptosis in pancreatic tumor cell lines

Xiao Ling Ding, Guo Xiong Zhou, Xiao Rong Zhou, Xiao Ying Wang

Research output: Contribution to journalArticle

Abstract

AIM: To investigate the effects and the mechanism of triptolide (TL) on proliferation and apoptosis of pancreatic cancer in vitro. METHODS: Pancreatic tumor cell lines PANC-1, ASPC-1 and SW1990 were treated with different concentrations of TL for 24 h and then, cell death was determined by Typan Blue Staining. Annexin V/PI double staining was performed to evaluate TL-induced apoptosis using flow cytometry. The expression of 5-lipoxygenase (5-LOX) and concentration of its downstream product LTB4 were determined by real time PCR, Western blot and ELISA. 5-LOX cDNA stable transfected SW1990 cells were established successfully. After treatment with TL, it was examined for overexpression of 5-LOX on TL-induced apoptosis. RESULTS: TL induced prominent growth inhibition and apoptosis in human pancreatic cancer cell lines. After treatment at 50 μg/L, the cell viability was 70.5% ± 6.8%, 61.2% ± 5.6% and 52.8% ± 5.3% of PANC-1, ASPC-1 and SW1990, respectively, which were significantly decreased compared with control group (P < 0.05). The apoptosis at 12 h evaluated by AnnexinV positive cells increased in TL-treated group compared with control group (24.2 ± 3.23 vs 9.5 ± 2.18, P < 0.05). TL significantly down-regulated 5-LOX expression in these cell lines and decreased LTB4 concentration in supernatant (P < 0.01, compared with control group). Furthermore, overexpression of 5-LOX in SW1990 cells made them more resistant to TL induced apoptosis, significantly inhibited the TL mediated cell death and apoptosis (P < 0.01 or 0.05, compared with control group). CONCLUSION: Inhibition of 5-LOX pathway of arachidonic acid metabolism is associated with TL's anti-proliferation and pro-apoptotic activity. It also provides evidence that TL has clinic therapeutic value for patients with pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)3835-3839
Number of pages5
JournalWorld Chinese Journal of Digestology
Volume16
Issue number34
StatePublished - Dec 2008

Fingerprint

Arachidonate 5-Lipoxygenase
Metabolic Networks and Pathways
Tumor Cell Line
Apoptosis
Pancreatic Neoplasms
Control Groups
Leukotriene B4
triptolide
Cell Death
Staining and Labeling
Cell Line
Annexin A5
Real-Time Polymerase Chain Reaction
Cell Survival
Flow Cytometry
Therapeutics
Complementary DNA
Western Blotting
Enzyme-Linked Immunosorbent Assay

Keywords

  • 5-Lipoxygenase
  • Pancreatic cancer
  • Triptolide

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Triptolide suppresses 5-lipoxygenase metabolic pathway and induces apoptosis in pancreatic tumor cell lines. / Ding, Xiao Ling; Zhou, Guo Xiong; Zhou, Xiao Rong; Wang, Xiao Ying.

In: World Chinese Journal of Digestology, Vol. 16, No. 34, 12.2008, p. 3835-3839.

Research output: Contribution to journalArticle

Ding, Xiao Ling ; Zhou, Guo Xiong ; Zhou, Xiao Rong ; Wang, Xiao Ying. / Triptolide suppresses 5-lipoxygenase metabolic pathway and induces apoptosis in pancreatic tumor cell lines. In: World Chinese Journal of Digestology. 2008 ; Vol. 16, No. 34. pp. 3835-3839.
@article{a37005b137164103b0b099acdb1f1b41,
title = "Triptolide suppresses 5-lipoxygenase metabolic pathway and induces apoptosis in pancreatic tumor cell lines",
abstract = "AIM: To investigate the effects and the mechanism of triptolide (TL) on proliferation and apoptosis of pancreatic cancer in vitro. METHODS: Pancreatic tumor cell lines PANC-1, ASPC-1 and SW1990 were treated with different concentrations of TL for 24 h and then, cell death was determined by Typan Blue Staining. Annexin V/PI double staining was performed to evaluate TL-induced apoptosis using flow cytometry. The expression of 5-lipoxygenase (5-LOX) and concentration of its downstream product LTB4 were determined by real time PCR, Western blot and ELISA. 5-LOX cDNA stable transfected SW1990 cells were established successfully. After treatment with TL, it was examined for overexpression of 5-LOX on TL-induced apoptosis. RESULTS: TL induced prominent growth inhibition and apoptosis in human pancreatic cancer cell lines. After treatment at 50 μg/L, the cell viability was 70.5{\%} ± 6.8{\%}, 61.2{\%} ± 5.6{\%} and 52.8{\%} ± 5.3{\%} of PANC-1, ASPC-1 and SW1990, respectively, which were significantly decreased compared with control group (P < 0.05). The apoptosis at 12 h evaluated by AnnexinV positive cells increased in TL-treated group compared with control group (24.2 ± 3.23 vs 9.5 ± 2.18, P < 0.05). TL significantly down-regulated 5-LOX expression in these cell lines and decreased LTB4 concentration in supernatant (P < 0.01, compared with control group). Furthermore, overexpression of 5-LOX in SW1990 cells made them more resistant to TL induced apoptosis, significantly inhibited the TL mediated cell death and apoptosis (P < 0.01 or 0.05, compared with control group). CONCLUSION: Inhibition of 5-LOX pathway of arachidonic acid metabolism is associated with TL's anti-proliferation and pro-apoptotic activity. It also provides evidence that TL has clinic therapeutic value for patients with pancreatic cancer.",
keywords = "5-Lipoxygenase, Pancreatic cancer, Triptolide",
author = "Ding, {Xiao Ling} and Zhou, {Guo Xiong} and Zhou, {Xiao Rong} and Wang, {Xiao Ying}",
year = "2008",
month = "12",
language = "English (US)",
volume = "16",
pages = "3835--3839",
journal = "World Chinese Journal of Digestology",
issn = "1009-3079",
publisher = "WJC Press",
number = "34",

}

TY - JOUR

T1 - Triptolide suppresses 5-lipoxygenase metabolic pathway and induces apoptosis in pancreatic tumor cell lines

AU - Ding, Xiao Ling

AU - Zhou, Guo Xiong

AU - Zhou, Xiao Rong

AU - Wang, Xiao Ying

PY - 2008/12

Y1 - 2008/12

N2 - AIM: To investigate the effects and the mechanism of triptolide (TL) on proliferation and apoptosis of pancreatic cancer in vitro. METHODS: Pancreatic tumor cell lines PANC-1, ASPC-1 and SW1990 were treated with different concentrations of TL for 24 h and then, cell death was determined by Typan Blue Staining. Annexin V/PI double staining was performed to evaluate TL-induced apoptosis using flow cytometry. The expression of 5-lipoxygenase (5-LOX) and concentration of its downstream product LTB4 were determined by real time PCR, Western blot and ELISA. 5-LOX cDNA stable transfected SW1990 cells were established successfully. After treatment with TL, it was examined for overexpression of 5-LOX on TL-induced apoptosis. RESULTS: TL induced prominent growth inhibition and apoptosis in human pancreatic cancer cell lines. After treatment at 50 μg/L, the cell viability was 70.5% ± 6.8%, 61.2% ± 5.6% and 52.8% ± 5.3% of PANC-1, ASPC-1 and SW1990, respectively, which were significantly decreased compared with control group (P < 0.05). The apoptosis at 12 h evaluated by AnnexinV positive cells increased in TL-treated group compared with control group (24.2 ± 3.23 vs 9.5 ± 2.18, P < 0.05). TL significantly down-regulated 5-LOX expression in these cell lines and decreased LTB4 concentration in supernatant (P < 0.01, compared with control group). Furthermore, overexpression of 5-LOX in SW1990 cells made them more resistant to TL induced apoptosis, significantly inhibited the TL mediated cell death and apoptosis (P < 0.01 or 0.05, compared with control group). CONCLUSION: Inhibition of 5-LOX pathway of arachidonic acid metabolism is associated with TL's anti-proliferation and pro-apoptotic activity. It also provides evidence that TL has clinic therapeutic value for patients with pancreatic cancer.

AB - AIM: To investigate the effects and the mechanism of triptolide (TL) on proliferation and apoptosis of pancreatic cancer in vitro. METHODS: Pancreatic tumor cell lines PANC-1, ASPC-1 and SW1990 were treated with different concentrations of TL for 24 h and then, cell death was determined by Typan Blue Staining. Annexin V/PI double staining was performed to evaluate TL-induced apoptosis using flow cytometry. The expression of 5-lipoxygenase (5-LOX) and concentration of its downstream product LTB4 were determined by real time PCR, Western blot and ELISA. 5-LOX cDNA stable transfected SW1990 cells were established successfully. After treatment with TL, it was examined for overexpression of 5-LOX on TL-induced apoptosis. RESULTS: TL induced prominent growth inhibition and apoptosis in human pancreatic cancer cell lines. After treatment at 50 μg/L, the cell viability was 70.5% ± 6.8%, 61.2% ± 5.6% and 52.8% ± 5.3% of PANC-1, ASPC-1 and SW1990, respectively, which were significantly decreased compared with control group (P < 0.05). The apoptosis at 12 h evaluated by AnnexinV positive cells increased in TL-treated group compared with control group (24.2 ± 3.23 vs 9.5 ± 2.18, P < 0.05). TL significantly down-regulated 5-LOX expression in these cell lines and decreased LTB4 concentration in supernatant (P < 0.01, compared with control group). Furthermore, overexpression of 5-LOX in SW1990 cells made them more resistant to TL induced apoptosis, significantly inhibited the TL mediated cell death and apoptosis (P < 0.01 or 0.05, compared with control group). CONCLUSION: Inhibition of 5-LOX pathway of arachidonic acid metabolism is associated with TL's anti-proliferation and pro-apoptotic activity. It also provides evidence that TL has clinic therapeutic value for patients with pancreatic cancer.

KW - 5-Lipoxygenase

KW - Pancreatic cancer

KW - Triptolide

UR - http://www.scopus.com/inward/record.url?scp=61349161086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349161086&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 3835

EP - 3839

JO - World Chinese Journal of Digestology

JF - World Chinese Journal of Digestology

SN - 1009-3079

IS - 34

ER -